Verwendung von Benzotriazinen als PLA2-Inhibitoren und neue Benzotriazine
申请人:BOEHRINGER MANNHEIM GMBH
公开号:EP0675881B1
公开(公告)日:1997-03-19
METHODS FOR TREATING TYROSINE-KINASE-INHIBITOR-RESISTANT MALIGNANCIES IN PATIENTS WITH GENETIC POLYMORPHISMS OR AHI1 DYSREGULATIONS OR MUTATIONS EMPLOYING DIANHYDROGALACTITOL, DIACETYLDIANHYDROGALACTITOL, DIBROMODULCITOL, OR ANALOGS OR DERIVATIVES THEREOF
申请人:Del Mar Pharmaceuticals
公开号:EP2872161A2
公开(公告)日:2015-05-20
USE OF DIANHYDROGALACTITOL AND ANALOGS AND DERIVATIVES THEREOF TO TREAT RECURRENT MALIGNANT GLIOMA OR PROGRESSIVE SECONDARY BRIAN TUMOR
申请人:Del Mar Pharmaceuticals
公开号:EP3003321A2
公开(公告)日:2016-04-13
THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS